GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MediPharm Labs Corp (STU:MLZ) » Definitions » Short Percentage of Float

MediPharm Labs (STU:MLZ) Short Percentage of Float


View and export this data going back to 2019. Start your Free Trial

What is MediPharm Labs Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of MediPharm Labs's Short Percentage of Float

For the Drug Manufacturers - Specialty & Generic subindustry, MediPharm Labs's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MediPharm Labs's Short Percentage of Float Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MediPharm Labs's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where MediPharm Labs's Short Percentage of Float falls into.


MediPharm Labs (STU:MLZ) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MediPharm Labs Corp (STU:MLZ) » Definitions » Short Percentage of Float
Comparable Companies
TSXV:CANB XCNQ:BNXT XCNQ:TIUM.U TSXV:PCLO XCNQ:GWAY TSX:AVCN XCNQ:VEXT XCNQ:BZAM XCNQ:RWB XCNQ:LEEF ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
MEDIF:USA MLZ:Germany LABS:Canada
Address
151 John Street, Barrie, ON, CAN, L4N 2L1
Website
https://www.medipharmlabs.com
MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis extracts and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.

MediPharm Labs (STU:MLZ) Headlines

No Headlines